Prasad Gabbita | Chief Executive Officer
P2d Inc

Prasad Gabbita, Chief Executive Officer, P2d Inc

Prasad Gabbita, Ph.D., has led the preclinical drug discovery, development and biomarker assay programs at P2D Bioscience for the past 12 years.  He brings 20 years of research experience and knowledge in neuroscience, toxicology, synthetic organic chemistry and drug formulation.  Prasad received his doctoral and post-doctoral training at the University of Kentucky College of Medicine and Sanders Brown Center on Aging in Lexington.  He has been the recipient of continuous research funding for drug and diagnostic development from several agencies including the Michael J. Fox Foundation, the Alzheimer’s Drug Discovery Foundation and the National Institutes of Health.  Prasad has authored more than 20 peer-reviewed scientific publications and book chapters


World Orphan Drug Congress USA 2018 - Conference Day Two @ 15:20

Oral, centrally acting TNF-α inhibitors for CNS inflammatory diseases including Frontotemporal Dementia (FTD)

back to speakers